Process for the purification of macrolide antibiotics
The present invention concerns a process for the purification of macrolide antibiotics. More specifically it concerns a process for the purification of macrolide antibiotics that result in a white powder. The powder remains white also after some time of storage. The process of the present invention is performed by dissolving the macrolide antibiotics, e.g. commercial vancomycin hydrochloride, in water and subjecting the solution to ultrafiltration with a membrane having nominal retention lower than 30,000 Da, preferably of 10,000 Da. The purified solution is preferably concentrated by reversed osmosis and then lyophilized at the optimized conditions of pressure and temperature to obtain a white powder.
1. A process of removing color impurities from a powder form of vancomycin comprising:
dissolving the powder form of vancomycin in water; and
subjecting the water solution of vancomycin to ultrafiltration with a membrane having nominal retention lower than 30,000 Da; whereby color impurities of the vancomycin are removed.
2. The process according to claim 1 wherein the membrane has nominal retention equal to or lower than 10,000 Da.
3. The process according to claim 1 wherein, after ultrafiltration, the purified solution is lyophilized at the optimized conditions of pressure and temperature to obtain a white powder.
4. The process according to claim 2 wherein, after ultrafiltration, the purified solution is lyophilized at the optimized conditions of pressure and temperature to obtain a white powder.
5. The process according to claim 3 wherein the final powder has absorption at 450 nm lower than 0.100.
6. The process according to claim 4 wherein the final powder has absorption at 450 nm lower than 0.100.
7. The process according to claim 3 wherein the final powder has absorption at 450 nm lower than 0.080.
8. The process according to claim 4 wherein the final powder has absorption at 450 nm lower than 0.080.
9. The process according to claim 3 , wherein before lyophilization, the purified solution is concentrated by reverse osmosis.
10. The process according to claim 4 , wherein before lyophilization, the purified solution is concentrated by reverse osmosis.
11. The process of claim 1 , wherein the powder form of vancomycin to be dissolved in water is of commercial grade.
12. The process of claim 1 , wherein the powder form of vancomycin to be dissolved in water contains light pinkish and/or brownish color impurities.
13. The process of claim 1 , wherein the powder form of vancomycin to be dissolved in water has absorption at 450 nm of about 0.184 or higher.
14. A process of removing color impurities from powder form a of vancomycin, wherein the method consists of:
dissolving the powder form of vancomycin in water;
removing color impurities of vancomycin by subjecting the water solution of vancomycin to ultrafiltration with a membrane having nominal retention lower than 30,000 Da to obtain a purified vancomycin solution; and, optionally,
concentrating and/or lyophilizing the purified vancomycin solution to obtain a white powder.
15. The process of claim 14 , wherein the membrane has nominal retention equal to or lower than 10,000 Da.
16. The process of claim 14 , wherein after ultrafiltration the purified solution is lyophilized at the optimized conditions of pressure and temperature to obtain a white powder.
17. The process of claim 16 , wherein before lyophilization the purified solution is concentrated by reverse osmosis.
18. The process of claim 14 , wherein the powder form of vancomycin to be dissolved in water is of commercial grade.
19. The process of claim 14 , wherein the powder form of vancomycin to be dissolved in water contains light pinkish and/or brownish color impurities.
20. The process of claim 14 , wherein the powder form of vancomycin to be dissolved in water has absorption at 450 nm of about 0.184 or higher.
21. The process according to claim 14 , wherein the obtained white powder has absorption at 450 nm lower than 0.100.
22. The process according to claim 14 , wherein the obtained white powder has absorption at 450 nm lower than 0.080.